Supernus Pharmaceuticals (SUPN) Receives Fourth U.S. Patent for Oxtellar XR
Tweet Send to a Friend
Supernus Pharmaceuticals (NASDAQ: SUPN) announced the issuance of a fourth patent (number 8,821,930) by the United States Patent and Trademark ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
